Hexagon Capital Partners’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-647
Closed -$4.7K 1161
2025
Q1
$4.7K Hold
647
﹤0.01% 1188
2024
Q4
$4.46K Buy
647
+621
+2,388% +$4.27K ﹤0.01% 1232
2024
Q3
$192 Buy
+26
New +$243 ﹤0.01% 1494
2024
Q2
Sell
-7
Closed -$97 1508
2024
Q1
$97 Sell
7
-7
-50% -$109 ﹤0.01% 1429
2023
Q4
$272 Sell
14
-23
-62% -$424 ﹤0.01% 1337
2023
Q3
$785 Sell
37
-147
-80% -$3.82K ﹤0.01% 1220
2023
Q2
$6.11K Sell
184
-41
-18% -$1.51K ﹤0.01% 859
2023
Q1
$8.85K Sell
225
-62
-22% -$2.58K ﹤0.01% 759
2022
Q4
$12.1K Buy
287
+93
+48% +$3.58K ﹤0.01% 673
2022
Q3
$6K Buy
194
+168
+646% +$7K ﹤0.01% 901
2022
Q2
$1K Buy
+26
New +$1.19K ﹤0.01% 1095

Other funds holding NUS

Hexagon Capital Partners's NUS Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Nu Skin (NUS) in Q2 2025, closing a stake of 647 shares — an estimated $4.7K sold.

Hexagon Capital Partners first reported a position in NUS in Q2 2022 and held it in 11 quarters. The position peaked at $12.1K in Q4 2022. 179 funds tracked by Wall St. Rank hold NUS as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Nu Skin position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 647 Nu Skin shares in Q2 2025, an estimated $4.7K.
  • Hexagon Capital Partners first reported a position in Nu Skin in Q2 2022 and held it in 11 quarters.
  • Hexagon Capital Partners's Nu Skin position peaked at $12.1K in Q4 2022.
  • 179 funds tracked by Wall St. Rank held Nu Skin as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.